Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - A1 Telekom Austria, Valneva (23/08/2021)

29.08.2021

A1 Telekom Austria: Nokia announced that it has been selected by A1 Telekom Austria Group (A1) to extend its 5G footprint outside of Austria into Bulgaria, Serbia, and Slovenia. The multi-country single vendor deal will see Nokia provide 5G RAN solutions from its comprehensive AirScale portfolio to all three markets and 5G Standalone core network to Serbia and Slovenia. The deployment is already underway in Bulgaria and is expected to start imminently in all other markets. Nokia is already providing comprehensive 5G coverage across Austria and will evolve its strategic partnership with A1 with this expanded deal. Nokia will provide equipment from its AirScale portfolio including 5G RAN and other Nokia AirScale radio access products which will deliver incredible speeds, connectivity, and capacity to their subscribers.
Telekom Austria: weekly performance: -0.40%

Valneva: Valneva, the Austrian/French specialty vaccine company focused on prophylactic vaccines for infectious diseases, today commenced  rolling submission, for initial approval of its COVID-19 vaccine candidate, VLA2001, with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK). VLA2001 is a whole virus, inactivated, adjuvanted vaccine candidate and is the only vaccine candidate of this type currently in clinical trials in Europe. VLA2001 is currently being studied in the UK in a pivotal Phase 3 trial, “Cov-Compare” (VLA2001-301), for which topline results are currently expected early in the fourth quarter 2021. Subject to positive Cov-Compare data and MHRA review, Valneva believes that initial approval could be granted before the end of 2021. In September 2020, Valneva announced a collaboration with the UK Government, which has the option to purchase up to 190 million doses through 2025. So far, the UK Government has ordered 100 million doses for supply in 2021 and 2022.
Valneva: weekly performance: 20.58%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (23/08/2021)


Partners









latest 21st Austria

21st Austria weekly - A1 Telekom Austria, Valneva (23/08/2021)


29.08.2021, 2016 Zeichen



A1 Telekom Austria: Nokia announced that it has been selected by A1 Telekom Austria Group (A1) to extend its 5G footprint outside of Austria into Bulgaria, Serbia, and Slovenia. The multi-country single vendor deal will see Nokia provide 5G RAN solutions from its comprehensive AirScale portfolio to all three markets and 5G Standalone core network to Serbia and Slovenia. The deployment is already underway in Bulgaria and is expected to start imminently in all other markets. Nokia is already providing comprehensive 5G coverage across Austria and will evolve its strategic partnership with A1 with this expanded deal. Nokia will provide equipment from its AirScale portfolio including 5G RAN and other Nokia AirScale radio access products which will deliver incredible speeds, connectivity, and capacity to their subscribers.
Telekom Austria: weekly performance: -0.40%

Valneva: Valneva, the Austrian/French specialty vaccine company focused on prophylactic vaccines for infectious diseases, today commenced  rolling submission, for initial approval of its COVID-19 vaccine candidate, VLA2001, with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK). VLA2001 is a whole virus, inactivated, adjuvanted vaccine candidate and is the only vaccine candidate of this type currently in clinical trials in Europe. VLA2001 is currently being studied in the UK in a pivotal Phase 3 trial, “Cov-Compare” (VLA2001-301), for which topline results are currently expected early in the fourth quarter 2021. Subject to positive Cov-Compare data and MHRA review, Valneva believes that initial approval could be granted before the end of 2021. In September 2020, Valneva announced a collaboration with the UK Government, which has the option to purchase up to 190 million doses through 2025. So far, the UK Government has ordered 100 million doses for supply in 2021 and 2022.
Valneva: weekly performance: 20.58%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (23/08/2021)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #637: Egalite Addiko und Marinomed, AT&S nach 2 Monaten zurück, 19 Jahre RBI an der Börse, Strabag top




 

Bildnachweis

Aktien auf dem Radar:Addiko Bank, Immofinanz, Marinomed Biotech, Flughafen Wien, Warimpex, EuroTeleSites AG, ATX Prime, ams-Osram, AT&S, Palfinger, RBI, Strabag, Pierer Mobility, UBM, CA Immo, Frequentis, Lenzing, SW Umwelttechnik, Oberbank AG Stamm, Wolford, Agrana, Amag, Erste Group, EVN, Kapsch TrafficCom, OMV, Österreichische Post, Telekom Austria, Uniqa, VIG, Wienerberger.


Random Partner

Sportradar
Sportradar ist ein Technologieunternehmen, das Erlebnisse für Sportfans schafft. Das 2001 gegründete Unternehmen ist an der Schnittstelle zwischen Sport-, Medien- und Wettbranche gut positioniert und bietet Sportverbänden, Medien und Sportwettanbietern eine Reihe von Lösungen, die sie unterstützen, ihr Geschäft auszubauen. Sportradar beschäftigt mehr als 2.300 Vollzeitmitarbeiter in 19 Ländern auf der ganzen Welt.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten